Trial intelligence / Profile preview

Remimazolam vs propofol for cerebral oxygen saturation and postoperative cognition in elderly laparoscopic colorectal cancer surgery

ChiCTR2500106681Phase 4Completed

Sponsor
Linyi People's Hospital
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in colorectal cancer (CRC) (2 arms), sponsored by Linyi People's Hospital. Primary endpoint: cerebral oxygen saturation. Started Jul 2025; status: completed.

02

Drugs

remimazolam
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on ChiCTR2500106681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500106681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call